---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-021612"
form_type: "8-K"
ticker: "GYRE"
cik: "0001124105"
company_name: "GYRE THERAPEUTICS, INC."
filed_at: "2025-06-06T23:59:59+00:00"
generated_at: "2026-05-19T18:04:05.524223+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Gyre Therapeutics reports shareholder meeting results; all proposals approved

## Summary
- Gordon Carmichael, Ph.D., elected as Class I director with 69,249,334 votes for, 297,881 withheld.
- Songjiang Ma elected with 69,385,506 votes for, 161,709 withheld; Ping Zhang with 69,320,687 for, 226,528 withheld.
- Non-binding advisory vote on executive compensation approved: 69,505,961 for, 39,318 against, 1,936 abstained.
- Ratification of Grant Thornton Zhitong as independent auditor for FY2025 approved: 72,175,754 for, 3,738 against, 146,263 abstained.
- Total shares entitled to vote: 93,742,602; broker non-votes reported for director elections and compensation vote.

## SEC filing metadata
- accession: 0001140361-25-021612
- form_type: 8-K
- ticker: GYRE
- cik: 0001124105
- company_name: GYRE THERAPEUTICS, INC.
- filed_at: 2025-06-06T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1124105/000114036125021612/0001140361-25-021612-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1124105/000114036125021612/ef20050192_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-021612
- JSON: https://secwatch.observer/filing/0001140361-25-021612.json
- Plain text: https://secwatch.observer/filing/0001140361-25-021612.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.